| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Director | Common Stock | 10K | $913K | $91.31 | Sep 11, 2024 | Direct |
| Axsome Therapeutics, Inc. | Director | Common Stock | 300 | $27.4K | $91.31 | Sep 11, 2024 | Indirect |
| Axsome Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | Sep 11, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics, Inc. | Sep 11, 2024 | 3 | -$965K | 4 | Sep 11, 2024 | Director |
| AXSM | Axsome Therapeutics, Inc. | Jun 7, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
| AXSM | Axsome Therapeutics, Inc. | Feb 27, 2024 | 1 | $0 | 4 | Feb 29, 2024 | Director |
| AXSM | Axsome Therapeutics, Inc. | Jun 2, 2023 | 1 | $0 | 4 | Jun 6, 2023 | Director |
| AXSM | Axsome Therapeutics, Inc. | Mar 2, 2023 | 1 | $0 | 4 | Mar 6, 2023 | Director |
| AXSM | Axsome Therapeutics, Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 7, 2022 | Director |
| AXSM | Axsome Therapeutics, Inc. | Mar 4, 2022 | 1 | $0 | 4 | Mar 8, 2022 | Director |
| AXSM | Axsome Therapeutics, Inc. | Nov 17, 2021 | 4 | $114K | 4 | Nov 19, 2021 | Director |
| AXSM | Axsome Therapeutics, Inc. | Jun 4, 2021 | 1 | $0 | 4 | Jun 8, 2021 | Director |